We report XCMS-MRM and METLIN-MRM (http://xcmsonline-mrm.scripps.edu/ and http://metlin.scripps.edu/), a cloud-based data-analysis platform and a public multiplereaction monitoring (MRM) transition repository for smallmolecule quantitative tandem mass spectrometry. This platform provides MRM transitions for more than 15,500 molecules and facilitates data sharing across different instruments and laboratories.
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(MS) analysis is widely used in the life sciences and medicine [2] [3] [4] [5] [6] [7] [8] [9] . Quantification is typically accomplished with a triple-quadrupole (QqQ) mass spectrometer configured to monitor a particular set of precursor-product ion transitions/reactions for molecules of interest 10 . The first quadrupole is set to select specific precursor ions, which are then fragmented in the second quadrupole acting as a collision cell. The resulting fragment ions are filtered by the third quadrupole before detection. This approach, known either as selected reaction monitoring (SRM) or MRM 9 is currently the gold standard for small-molecule quantitative analysis, owing to its high sensitivity and specificity. However, both precursor and product mass-to-charge ratios must be optimized for each target molecule with pure standard materials. In the proteomics field, public libraries such as SRMAtlas 10 or iMPAQT 11 have been developed to address this challenge and streamline targeted-peptide quantification throughput. These libraries provide a compendium of selected reaction-monitoring assays for targeting the human proteome. However, no equivalent public repository of such magnitude is currently available for the targeted analysis of small molecules or metabolites.
After data acquisition, computational processing is necessary to integrate each molecular-fragment signal and retrieve accurate concentrations. This processing, however, heavily relies on commercial and vendor-specific software, because relatively few freely available tools have been developed for such purposes (e.g., Skyline 12 , MRMAnalyzer 13 and MRMPROBS 14 )
. In this paper, we introduce XCMS-MRM and METLIN-MRM, a cloud-based data-analysis platform and a public library, respectively, which streamline experimental design, data processing, analysis and data sharing for targeted small-molecule analysis by MS (Fig. 1 ). This platform is publicly accessible at http://xcmsonlinemrm.scripps.edu/ and http://metlin.scripps.edu/.
The METLIN-MRM library is a compendium of small-molecule transitions for MRM MS. Currently, it contains transitions for more than 15,500 unique small molecules (Fig. 1) . In this resource, three different types of transitions are available: (i) traditional experimentally optimized (EO) transitions, (ii) computationally optimized (CO) experimental transitions and (iii) public repository (PR) transitions. EO transitions were acquired for more than 1,000 molecules in both positive and negative mode by following the established protocol 9 for the analysis of pure standards with two different liquid chromatography-QqQ systems across our laboratories (Agilent iFunnel 6495 QqQ and Sciex QTRAP 5500; Methods). These smallmolecule transitions allow for targeting a broad metabolite range, and in their optimization, the collision energy (CE) was tuned to retrieve the fragments showing the highest intensity.
In addition to experimentally acquired data, transitions for more than 14,000 and 4,700 molecules in positive and negative mode, respectively, were computationally optimized by using the METLIN spectral library 15 (acquired at different CEs on a qToF instrument) by ranking empirical MS/MS fragments according to their selectivity (uniqueness of a product fragment for a given molecule). The developed ranking algorithm (Methods) compares the MS/MS spectra of compounds with precursors within a ± 0.7-Da window, and fragments showing the best selectivity, without compromising intensity, are retained as transitions (Fig. 2a) . As many as three transitions were determined for each molecule, because the use of a single transition can lead to potential misidentification of molecules 16 . This strategy enabled high-throughput transition optimization, such that instead of optimizing transitions mainly on the basis of compound-dependent properties such as the signal-to-noise ratio, transitions were optimized by prioritizing the transitions less likely to be masked by shared transitions from interfering molecules (Fig. 2a,b) . In addition, METLIN-MRM allows users to rate these transitions, thus enabling cooperative validation by the community.
XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules
METLIN-MRM also serves as a public repository, in which community members can upload their own transitions. A curation team supervises user-submitted lists to ensure that the data follow a standardized format. Submitted lists of transitions are assigned with a unique accession number that can be used as a reference for publications. This process ultimately facilitates the deposition of transitions used in experiments and scientific literature into a standardized and searchable database, thereby increasing the traceability and reproducibility of experiments and the reuse/sharing of optimized transitions calculated by other laboratories. We launched this feature with a total of 3,300 transitions for more than 1,500 small molecules from eight peer-reviewed papers. These PR transitions will be displayed along their corresponding original source (doi) and will be downloadable.
A cloud-based workflow integrating METLIN-MRM with XCMS-MRM is illustrated in Fig. 1 . First, the transitions to be monitored for the different molecules are searched against the METLIN-MRM library. Experimentally optimized, computationally optimized or PR transitions can be selected ( Supplementary  Fig. 1 ). After data acquisition, raw data files, in any vendor format, are uploaded into the XCMS-MRM platform for quantitative data processing. Signal-processing techniques automatically detect, integrate and align the peaks across samples, minimizing false peak integration and reducing manual labor ( Supplementary  Fig. 2 ). This process yields relative molecule concentration levels, which can be converted to absolute values through the use of stable-isotope dilution assays, calibration curves by internal standard addition or external calibration. Additional peak-integration refinement can be manually conducted for transitions that might be affected by inherent tandem MS artifacts such as strong co-elution with interfering molecules or matrix effects. Finally, quantitative results are displayed, including quality-control indicators (allowing for assessment of accuracy and specificity, limits of detection and quantification and linear dynamic ranges) and biologically interpretable results and graphs (such as P values or fold changes) to assess the statistical significance of the metabolite concentration changes among phenotypes. The cloud-computing implementation allows data to be easily shared, thus facilitating interlaboratory collaboration ( Supplementary Fig. 3 ).
To validate the CO transitions (ranked) available in METLIN-MRM, we compared them against the EO (unranked). The unranked transitions were provided by two of our laboratories and by four independent laboratories that reported transitions in the scientific literature. For 641 molecules for which transitions were available in both groups, we observed that for 90% of the molecules, at least one ranked and unranked transition matched, and in 62% of the cases, both the fragment and CEs matched (Fig. 2c) . Moreover, we observed that for 60% of the transitions, the CE difference between the ranked (CO) and unranked (EO) transitions was below 5 V (Fig. 2d) , despite the limited discrete values available for the ranked transitions (10, 20 and 40 V). Furthermore, to determine whether the CE error for the ranked transitions was within the error range observed among unranked transitions, we determined, for each molecule, the maximum and minimum CE for the same experimentally optimized transitions among laboratories (those sharing the same fragment m/z value). We constructed a two-dimensional density plot of the maximum and minimum CEs found across laboratories (Fig. 2e) . At low CE (10 V), a 5-V error range might be expected, whereas at higher CE (20-40 V) , no significant error was observed. Interestingly, the general trend was that all the values determined experimentally through the standard protocol were centered among 10, 15, 20 and 40 V, in agreement with the discrete CE values provided by the ranked transitions from METLIN.
To further evaluate the quality of the CO (ranked) transitions, we evaluated their selectivity. We calculated the number of putative interfering molecules (PIMs) that shared the same transition, on the basis of a search in METLIN, and selected the number of PIMs of the most selective transition per molecule. We applied this procedure for the ranked and unranked transitions separately. We Users can play an active role in database curation through a transition quality rating system. In XCMS-MRM, the cloud-based workflow allows users to process, visualize and share data. The community can interactively visualize experiments made public by users and can use the accession numbers provided as a citation in literature.
then calculated the minimum PIM value per transition type (an indicator of the selectivity of the most selective transition) and plotted the ratio per molecule, calculated as the minimum PIM number of the unranked transitions divided by the minimum number of PIMs of the ranked transitions, with values > 1 and < 1 indicating higher selectivity for the unranked and ranked transitions, respectively (Fig. 2f) . A total of 61% of molecules had the same minimum PIM value, and among the remaining molecules, 35% had a selectivity fold change greater than one; i.e., ranked transitions were more selective than unranked transitions. . b, Experimental QqQ transitions are optimized by using standard materials and prioritizing high-intensity fragments (sensitivity), which might yield nonspecific fragments (for example, red fragment) and thus misidentifications. c, Percentage of a total of 641 molecules sharing at least one or two or more transitions (taking m/z and CE into account). Of note, the CEs in EO and PR transitions (unranked) were rounded to the nearest discrete value (10, 20 or 40 V). d, CE error distribution between CO (ranked) and unranked transitions (for those transitions with the same product-fragment value). e, Two-dimensional density plot of the maximum (max) and minimum (min) CEs for the same transition found across laboratories (EO and PR). f, Selectivity ratio: for each molecule, the ratio of the minimum number of PIMs of the unranked transitions to the minimum number of PIMs of the ranked transitions. The plot shows the number of molecules; unranked (red) and ranked (blue) transitions are more selective (ratios < 1 and > 1 indicate better selectivity for unranked and ranked transitions, respectively).
Interestingly, previous studies have reported a misidentification rate of 30% when a single transition per compound was used in combination with retention time 16 . The unranked transitions presented better selectivity in only 4% of the remaining cases. We found that these either were low-intensity fragments or fell outside the CE range of METLIN (40 V or above).
Overall, our results confirmed the statistical ranking as a valid complementary optimization strategy. As an example, molecules such as leucine and isoleucine showed different transitions after the statistical ranking, as compared with unranked transitions. This procedure allowed for the necessary fragment selectivity for the correct identification and quantification of the aforementioned molecules in a reverse-phase MRM configuration ( Supplementary  Fig. 4 ), which otherwise would have required additional assay development. Despite the increased ability of selective transitions to distinguish between similar molecules, in-source fragments from the same structure might be inaccurately attributed to the target molecule 17 . This is an important limitation that underlines the continuing need for chromatography and retention-time libraries to completely circumvent the need for standard materials. Finally, there is a compromise between quantitative response and selectivity; for example, selective transitions do not always have an optimal intensity response, and vice versa. Therefore, the use of a qualitative transition in addition to a quantitative transition is encouraged to increase both quantitative and qualitative method performance.
To further validate the METLIN-MRM transitions, 98 metabolites in a cell line (RAW264.7) were quantified with HILIC chromatography (Methods). Results showed a good agreement of the quantitative response between experimental and computationally optimized transitions (Supplementary Tables 1 and 2 ). Additionally, XCMS-MRM performance was assayed in a drug-quantification study involving 354 human blood samples (Methods). Drugquantification results from an accredited toxicology laboratory were compared with those from XCMS-MRM. All drugs and their metabolites were quantified, in most cases with relative errors below 10% (Supplementary Fig. 5 ). Additionally, six samples from the same pool of human-serum sample spiked with standards were analyzed and processed by XCMS-MRM in four different laboratories worldwide. The independent quantitative analysis of those molecules in all four laboratories with different vendor equipment led to similar quantitative results under expected instrumental and analytical error (median coefficient of variation between laboratories, 15%; Supplementary Tables 3 and 4). All laboratories shared their data and results through the XCMS-MRM platform without using third-party transmission systems or particular reports.
Together, METLIN-MRM and XCMS-MRM facilitate data acquisition, result sharing and increased reproducibility across laboratories. To our knowledge, METLIN-MRM constitutes the largest publicly available ensemble of MRM transitions for small molecules, thus allowing for targeted identification and quantification of a large number of endogenous and exogenous molecules. METLIN-MRM streamlines quantitative analyses with minimal resources and development time and also serves as a PR allowing the community to upload, share and cite experimental transitions through accession numbers.
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Methods

Experimental transition optimization via QqQ tandem mass spectrometry.
Transitions were optimized according to the established optimization protocol 9 . Briefly, for each standard infused in the MS, the CE is tuned to retrieve the fragments showing the highest intensity. This approach yields a transition with a specific CE that can be used for quantification. Most of the material standards used for transition optimization were purchased from Sigma-Aldrich. Transitions were acquired in two laboratories using two QqQ mass spectrometers. In the first laboratory, flow-injection analysis with an UHPLC system (1290 series, Agilent Technologies) coupled to a Triple quadrupole 6495 (Agilent Technologies) mass spectrometer was used. The MS was operated in single reaction monitoring mode by using the Optimizer to automatically optimize the CEs and product ions for each metabolite. The cycle time was 500 ms. The ESI source conditions were set as follows: dry-gas temperature, 230 °C; drying gas, 14 l/min; nebulizer, 40 psi; sheath-gas temperature, 400 °C; sheath-gas flow, 12 l/min; nozzle voltage, 500 V; and capillary voltage, 3,500 V in ESI positive and 2,000 V in negative mode. The analyses were performed in ESI positive mode with an isocratic gradient, 50% 20 mM ammonium acetate, 0.1% formic acid in water and 50% 0.1% formic acid in acetonitrile for 1 min. In ESI negative mode, the isocratic gradient, 50% 10 mM ammonium acetate in water and 50% acetonitrile was applied, also during 1 min. The flow rate was 400 µ L/min, and the injection volume was 2 μ L for all analyzed standards. Standard-compound mixtures were reconstituted in methanol/water 5:95 (vol/vol), transferred to HPLC vials and stored at − 80 °C before flow-injection analysis.
The second laboratory used a QTRAP 5500 (Sciex) coupled to a LC Dionex Ultimate 3000 (Dionex, Thermo Scientific). Analyses were performed in positive and negative electrospray ionization with a TurboV ion source. The chromatographic separation was performed on a Kinetex C18 column (100 × 2.1 mm, 2.6 µ m). The mobile phases were composed of A, 0.1% formic acid in H 2 O; B, 0.1% formic acid in acetonitrile (ACN) for the positive mode. In the negative mode, the mobile phases were A, 0.5 mM ammonium fluoride in water; B, 0.5 mM ammonium fluoride in ACN. The run started at 2% B for 1.5 min, was ramped to 98% B during 5 min, held at 98% B for an additional 2 min, ramped down to 2% B in 0.5 min and reequilibrated for the rest of the run.
Transition optimization via computational ranking. The METLIN-MRM statistical-optimization algorithm was designed for high-throughput transition optimization. The algorithm aims at finding the most selective transitions for each molecule by comparing experimental MS/MS spectra from the METLIN library among molecules with a precursor within a ± 0.7-Da window. For each given target molecule in the METLIN library, a two-step strategy to optimize their transitions was applied: (i) determining the maximum CE to be considered and (ii) determining up to three transitions per molecule. These three transitions are determined with three slightly different methods and aim at mimicking the routine MRM transition setup composed of a quantitative and two qualitative transitions.
In the first step (i), we aim to determine the maximum CE that we can apply to each compound without compromising sensitivity. In general, higher CEs applied to a compound result in lower fragment intensities, especially when the molecule is at low concentration (a common situation in real samples). It is then of special importance to limit the CE to be applied to each molecule. In that sense, to determine this maximum CE, the algorithm compares the intensity of the precursor ion among different CEs (10, 20 and 40 V), and it retains those CEs where the precursor signal is still detected. This is an indirect (nonexperimental) way to measure the rate of dissociation of the precursor and thus an optimal maximum CE. After the maximum CE for each compound is determined, the algorithm proceeds to step (ii), which consists of calculating the selective fragments. In this step, for a given target molecule, METLIN is searched for all molecules with a precursor within a ± 0.7-Da window (typical quadrupole mass resolution). We refer to these molecules as PIMs throughout the text. Next, for each fragment and CE of the target-molecule MS/MS spectrum, an intensity density value is determined, calculated as the sum of the intensities of the same fragment in the PIM's MS/MS spectra ( Supplementary Fig. 4a ). This value acts as an indicator of the selectivity (uniqueness) of a certain fragment for a given molecule. A low-density value indicates that this fragment has a low or null intensity in the rest of interfering molecules and thus has a high degree of selectivity. The fragment with the highest degree of selectivity is retained as a qualitative fragment. Only fragments with an intensity (relative to the highest peak) above 20% are considered. To determine the second and third transitions, the algorithm determines the maximum interfering spectra, composed by all fragments across all PIM spectra, retaining the intensity of the most intense fragment when the same fragment is present in two or more spectra. Then the algorithm selects the two remaining transitions by retaining those showing the largest absolute (equation (1)) and relative (equation (2)) intensity distance between the target and the maximum interfering spectra.
Where T t and T l are the fragment indexes for the quantitative and qualitative transitions, and index i denotes each of the shared fragments in the target spectrum x and the maximum interfering spectrum y. The absolute distance prioritizes the fragments showing the best intensity response, while taking into account the selectivity of each fragment (quantitative transition). The relative distance prioritizes highly selective fragments (secondary qualitative transition). This strategy maximizes the Pareto efficiency 18 of the process; that is, it determines a set of fragments showing optimal selectivity without compromising intensity. Of note, common neutral losses, including loss of water and carbon dioxide for positive and negative mode, and loss of ammonia for positive mode, are not considered for qualitative transitions but are considered for quantitative transitions.
To determine the second and third transitions, the algorithm considers only fragments appearing in interfering spectra that share the qualitative fragment (first transition). This is to prevent other putative interfering molecules from sharing all the same three transitions (Supplementary Fig. 4c) . Thus, the combined use of these transitions translates into a more confident quantification of this target molecule when their peak area/concentration show a high linear relation. Consequently, the three transitions should lead to the same absolute concentrations, and only when another compound is interfering can different concentrations be obtained. Overall, METLIN-MRM's computationally optimized transitions have a lower likelihood of being masked by other interfering molecules, in comparison with experimentally optimized transitions. In addition, METLIN-MRM facilitates the identification of interferences when they are present.
Validation of METLIN-MRM transitions.
The experimental validation of the computationally optimized transitions was performed by analyzing 98 metabolites (74 of which had both CO and EO transitions, and 24 of which had only CO transitions (Supplementary Tables 1 and 2 ) at six different concentrations (unspiked and five spiked samples) in a mouse cell line (RAW264.7) with HILIC chromatography (HPLC and UPLC) in both positive-and negative-ion modes with Waters TQ-XS and Agilent 6495 QqQ instrumentation, respectively ('Smallmolecule extraction and tandem QqQ/MRM analysis' section). R 2 values between the real concentration and peak area were determined. Among the 74 compounds, 62 had R 2 values above 0.8 for both CO and EO transitions, thus demonstrating a linear response and validating both types of transitions (Supplementary Tables 1  and 2 ). However, the compounds with R 2 values below 0.8 showed a high linear relationship between CO and EO transition peak areas, thus indicating that the CO transition performance is comparable to that of EO transitions. Furthermore, 24 other metabolites were analyzed with the CO transitions (EO transitions were not available), and 20 had R 2 values above 0.8 (Supplementary Table 2 ), thus increasing the number to a total of 82 validated metabolite transitions.
XCMS-MRM automated data-processing algorithm.
To process transition signals, first, automatic baseline-removal preprocessing is applied to subtract the baseline drift usually affecting LC/MS chromatograms, thus providing more reliable peak-area quantification. Similarly, as in previous work 19 , this baseline is approximated by a moving-minimum filter, according to a minimum compound peak width (a user-defined value in seconds). After preprocessing, a convolution between a Gaussian peak signal and the MS signal by means of a fast Fourier transform is applied to filter the signal and detect the different peak fragments. This Gaussian signal is calculated on the basis of the same user-defined minimum-peak-width parameter. If multiple transitions for the same metabolite are used, XCMS-MRM focuses on the information from all the transitions for a given compound and uses this information to detect the peak of interest more efficiently. This procedure is of special importance when more than one peak is found in a transition, and the peak related to the compound of interest can be identified only by inspecting the transitions (Supplementary Fig. 3 ). Unimodality through an isotonic regression is applied to the final chromatographic-peak profile to improve the quality of the extracted peak, to ensure that only one peak is integrated and thus minimize the interference of noise and low-concentration and co-eluted peaks 20 .
XCMS-MRM workflow.
After tandem MS measurements, raw data files are uploaded into the XCMS-MRM cloud platform. Raw data files can be uploaded in commonly accepted chromatography interchange open standard formats, mzML, or various vendor formats such as Agilent or Bruker.d files, Waters raw files or Sciex scan files. Many other vendor files can be easily translated into mzML with the broadly used ProteoWizard software 21 . Next, data are processed by XCMS-MRM to automatically detect and integrate fragment peaks. XCMS-MRM allows for multiple transitions for the same molecule, which are analyzed as a compound (for example, detecting the retention time when multiple peaks are found in a transition). To allow this automatic processing, users must provide a list of the target-molecule names along with their respective precursor ions and quantitative/ qualitative fragment m/z values. Details on the selection of those parameters are described in the XCMS-MRM documentation available in the cloud platform (XCMS Institute and Help Sections, which can be accessed after login at http://xcmsonline-mrm.scripps.edu/). After processing, XCMS-MRM provides a list of the target molecules, along with the mean retention time and the coefficient of determination (R 2 ) between integrated peak areas across samples. This R 2 , which ranges between 0 and 1, allows for rapid assessment of the automated processing results of XCMS-MRM, even when standards are not spiked. For example, values close to 0 mean that the quantitative and qualitative fragment peak areas do not follow a linear relation among samples, thereby suggesting the presence of coeluting molecules and/or suppression effects, and a manual review of the peak integration is necessary. R 2 values close to 1 suggest successful peak integration. Users can manually inspect the XCMS-MRM automated integration of each peak in each sample and adjust integration boundaries in the cases of strong co-elution or chromatographic shifts.
Interlaboratory analysis of tandem MS samples with XCMS-MRM.
To demonstrate the capabilities of XCMS-MRM as a cooperative resource, six samples from the same pool of human serum sample spiked with ten standards (standard addition calibration method; 'Small-molecule extraction and tandem QqQ/ MRM analysis' section and Supplementary Table 3) were analyzed and processed by XCMS-MRM in four different laboratories worldwide (The Scripps Research Institute, University of Umeå, University of Lausanne and Imperial College). The sample was analyzed with four different QqQ instruments including an Agilent iFunnel 6495 and 6490, a Sciex QTRAP 5500 and a Waters Xevo TQ-S. The results (Supplementary Table 4) showed the concentration of each metabolite in the sample, obtained with a calibration curve by standard addition. The independent quantitative analysis of those molecules in all four laboratories with different vendor equipment led to similar quantitative results under expected instrumental and analytical error (median coefficient of variation between laboratories, 15%). The quantitative analysis of cholesterol was discarded because its concentration was below the limit of quantification. In addition, because of its low concentration (median 30 nM), palmitoylcarnitine showed a high coefficient of variation.
Application of XCMS-MRM for drug and metabolite quantification. XCMS-MRM performance for high-throughput data processing was assayed in a drugquantification study involving 354 human blood samples, in which a supervised quantification of two drugs and two of their metabolites (six compounds in total) in an accredited toxicology laboratory was compared against the quantification by XCMS-MRM ('Small-molecule extraction and tandem QqQ/MRM analysis' section). The concentrations of cocaine, benzoylecgonine and cocaethylene were analyzed by QqQ MS in 57 whole blood samples in duplicate (114 samples), and the concentrations of tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-Nor-9-carboxy-THC were analyzed in 120 serum samples in duplicate (240 samples). We calculated the relative concentration error between XCMS-MRM and the reference values by the certified laboratory ( Supplementary Fig. 5 and 'Small-molecule extraction and tandem QqQ/MRM analysis' section). We observed that most of these errors were below 10%, thus demonstrating the ability of XCMS-MRM to accurately quantify small molecules. Of note, larger errors were observed for 11-hydroxy-THC, THC and 11-Nor-9-carboxy-THC than for cocaine, benzoylecgonine and cocaethylene. This result can be explained by the low ionization efficiency of the THC and its metabolites, together with their relatively low concentration in blood as a result of their pharmacokinetics. Therefore, a small difference in peak integration would induce a larger difference in the calculated concentration, independently of the peak-integration algorithm. For the interlaboratory quantitative analysis, the human serum (from healthy volunteers) was extracted with MeOH/ACN 1:1 (vol/vol) spiked with different concentrations of the metabolites listed in Supplementary Table 2 . Different instrumentation was used as in the different laboratories. A Sciex QTRAP 5500, an Agilent 6495 and a Waters Xevo TQ-S were used for this analysis. For the separation, reversed-phase chromatography was selected because this method is commonly used in laboratories. The chromatography settings for all laboratories were based on the following method with slight variations depending on availability at the different sites. An ACQUITY UPLC BEH C18 column (2.1 × 100 mm, 1.7 μ m, Waters) held at 50 °C was used. The mobile phases used were H 2 O + 0.1% formic acid and ACN + 0.1% formic acid from A and B, respectively. Sample (2 μ L) was injected, and a flow rate of 400 μ L/min was used. The gradient used was 99% A for 1 min to 1% A over 9 min and was held at 1% A for 1 min.
Small-molecule extraction and tandem
For the drug-quantification analysis, blood samples from roadside drug testing were used. Samples of 10 µ L (dried blood spot) and 1 mL of whole blood were used for the quantification of cocaine and THC, respectively. MeOH (200 µ L) was used for the extraction of cocaine. For the THC analysis, 200 µ L of acetic acid 10% in H 2 O (vol/vol), and 5 mL of hexane/ethyl acetate (9:1, vol/vol) were used as extraction solvents. The analysis was conducted in a QqQ 5000 (Sciex) coupled to an LC Ultimate 3000 (Dionex). The analysis of the cocaine and its metabolites was performed with a Kinetex HILIC column (50 × 2.1 mm, 2.6 μ m, Phenomenex). H 2 O (10 mM ammonium formate, pH 3.3) and ACN were used as mobile phases A and B, respectively. For THC and its metabolites, the analysis was performed with a Kinetex C18 column (50 × 2.1 mm, 2.6 μ m, Phenomenex). H 2 O (5 mM ammonium formate, pH 7.7) and ACN were used as mobile phases A and B, respectively. The gradient for cocaine analysis consisted of 3% A for 0.3 min and was increased to 30% A at 2.8 min, then to 50% A at 2.9 min, and was held for 1 min at a flow rate of 700 µ L/min. The gradient for THC analysis consisted of 70% A to 10% A in 2 min, and was then held at 10% A for 4 -diacetlyspermine in mouse plasma with calibration curves was conducted as described elsewhere 22 . Briefly, 8 µ L of plasma extract was injected into a Scherzo SM-C18 column (150 × 0.5 mm, 3 µ m, Imtakt) with an Agilent Technologies series 1290 UPLC with a gradient mobile phase of 5 mM ammonium acetate (mobile phase A) and 50 mM acetate and acetonitrile (1:1, vol/vol) (mobile phase B) at a flow rate of 20 µ L/min: 2% B for 5 min, to 17% B at 11 min, to 98% B at 13.5 min and was held for 5 min. The MRM transitions selected were m/z 287.2 → m/z 100.1 and m/z 287.2 → 171.1, and an Agilent 6495 QqQ mass spectrometer was used.
RAW264.7 macrophage-like cells were obtained from the American Type Culture Collection. The cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% (vol/vol) FBS, 100 U/ml penicillin and 100 μ g/ml streptomycin, and 2 mM l-glutamine at 37 °C in a humidified atmosphere of CO 2 / air (1:19). The cells were washed with PBS, scraped in ice-cold water and stored at − 80 °C before metabolite extraction and LC-MS/MS analysis.
The validation study of 97 metabolites in RAW264.7 cells was performed by spiking five samples with different concentrations of the 97 metabolites (six samples total, one unspiked and five spiked) and analyzed with both the ranked (computationally optimized) and unranked (experimentally optimized and PR, when available) transitions during the same run. For this analysis, two different HILIC methods were used; one with a UPLC column ACQUITY UPLC BEH Amide (2.1 × 100 mm, 1.7 μ m, Waters) in positive mode and the other with an HPLC column Luna HILIC (150 × 2 mm, 3 μ m, Phenomenex) in negative mode. The gradient for UPLC analysis consisted of (400 μ L/min flow rate) 99% A for 1 min, 35% A over 13 min, 60% A over 3 min and a hold at 60% A for 1 min. The composition for the mobile phases A and B consisted of H 2 O + 0.1% formic acid and ACN + 0.1% formic acid, respectively. The gradient for the HPLC analysis consisted of (300 μ L/min flow rate) 5% A for 2 min, 90% A over 13 min, 100% A over 3 min and a hold at 100% A for 3 min. Mobile phases A and B consisted of 5% ACN (40 mM ammonium acetate and 20 mM ammonium hydroxide) and 95%1 nature research | reporting summary 
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